Literature DB >> 3780754

Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cells.

F Capony, M Garcia, J Capdevielle, C Rougeot, P Ferrara, H Rochefort.   

Abstract

An estrogen-regulated 52-kDa glycoprotein secreted by MCF7 breast cancer cells was first purified from serum-free conditioned medium by concanavalin-A--Sepharose (ConA--Sepharose). The 13% pure protein was then used to obtain monoclonal antibodies to the 52-kDa protein [Garcia et al. (1985) Cancer Res. 45, 709-716]. Using ConA--Sepharose and monoclonal antibody affinity chromatographies, the secreted 52-kDa protein was finally purified to homogeneity as verified by silver staining of sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) and one single N-terminal amino acid. The purification factor was approximately 1400 and the yield 40%. The same two-step procedure, applied to MCF7 cell extracts, yielded four immunologically related proteins of 52 kDa, 48 kDa, 34 kDa and 17 kDa, which were purified 1250-fold with a yield of 30%. These components were further separated by high-performance liquid chromatography gel filtration under denaturing conditions. The final products were homogeneous on the basis of silver-stained SDS-PAGE and gel filtration. However, isoelectrofocusing showed that the pI of the secreted 52-kDa protein and the cellular 34-kDa protein varied from 5.5 to 6.5. Amino acid analysis of the secreted and the related cellular 34-kDa protein is given. Western immunoblotting, pulse chase studies and post-translational studies indicate that the 52-kDa protein is the precursors of a lysosomal enzyme which is partially secreted and partially processed into smaller cellular forms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780754     DOI: 10.1111/j.1432-1033.1986.tb10471.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line.

Authors:  K El Messaoudi; L F Thiry; C Liesnard; N Van Tieghem; A Bollen; N Moguilevsky
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Cathepsin D in breast cancer.

Authors:  H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

3.  Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells.

Authors:  B R Westley; F E May
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

Review 4.  Autocrine growth factors and solid tumor malignancy.

Authors:  J H Walsh; W E Karnes; F Cuttitta; A Walker
Journal:  West J Med       Date:  1991-08

Review 5.  Cathepsin D: a protease involved in breast cancer metastasis.

Authors:  H Rochefort; F Capony; M Garcia
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

6.  Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells.

Authors:  F Capony; M Morisset; A J Barrett; J P Capony; P Broquet; F Vignon; M Chambon; P Louisot; H Rochefort
Journal:  J Cell Biol       Date:  1987-02       Impact factor: 10.539

7.  Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer.

Authors:  O Falcón; R Chirino; L León; A López-Bonilla; S Torres; L Fernández; J A García-Hernández; P F Valerón; J C Díaz-Chico
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.